B · Normal
[Maike Pharmaceuticals rose more than 60% and planned to repurchase no more than 10% of H shares] On November 3, as of press time, Maike Pharmaceuticals-B (02335.HK) rose 63% to HK$19.58 per share, hitting an intraday high of HK$20.24, with a turnover of over HK$300 million. On the news, the company previously issued a proposal to adopt a ten-year H-share incentive plan and a general authorization announcement to repurchase H shares, allowing it to repurchase no more than 10% of the total number of issued H shares with its own funds.
Comments